|
Sign In to gain access to subscriptions and/or personal tools.
|
Norwegian Scholarships for the Master's and Doctoral Programs
References
- Chu, J.H., Gange, S.J.,Anastos, K., Minkoff, H., Cejtin, H., Bacon, M., Levine, A. and Greenblatt, R.M. (2005) Hormonal Contraceptive Use and the Effectiveness of Highly Active Antiretroviral Therapy , American Journal of Epidemiology 161 (9): 881–90 .[Abstract/Free Full Text]
- Cohn, S., Watts, D., Lertora, J., Park, J.G. and Yu, S. (2005) An Open-label, Nonrandomised Study of the Effect of Depo-medroxyprogesterone Acetate on the Pharmacokinetics of Selected Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors Therapies among HIV-infected Women , Presented at the 12th Conference on Retroviruses and Opportunistic Infections, Boston, February 22–25.
- Mildvan, D., Yarrish, R., Marshak, A., Hutman, H.W., McDonough, M., Lamson, M. and Robinson, P. (2002) Pharmacokinetic Interaction between Nevirapine and Ethinyl Estradiol/norethindrone when Administered Concurrently to HIV-infected Women , Journal of Acquired Immune Deficiency Syndromes 29 (5): 471–77 .[Medline]
[Order article via Infotrieve]
- Money, D.M. (2003) Antiviral and Antiretroviral Use in Pregnancy , Obstetrics and Gynecology Clinics of North America 30 (4): 731–49 .[CrossRef][Medline]
[Order article via Infotrieve]
- Piscitelli, S.C. and Gallicano, K.D. (2001) Interactions among Drugs for HIV and Opportunistic Infections , New England Journal of Medicine 344 (13): 984–96 .[Free Full Text]
- Preble, E.A., Huber, D. and Piwoz, E.G. (2003) Family Planning and the Prevention of Mother-to-child Transmission of HIV: Technical and Programmatic Issues, Arlington, Virginia, Advance Africa , February 21, 38 pp. (Available at http://www.advanceafrica.org/publications_and_presentations/Technical_Papers/TP_FP_and_PMTCT.pdf)
- Shelton, J.D. (2005) Contraception for Women on First-line Antiretrovirals (ARVs), Baltimore, The INFO Project at the Johns Hopkins Bloomberg School of Public Health/ Center for Communication Programs, March 25 (Global Health Technical Briefs) (Available: http://www.maqweb.org/techbriefs/tb5arv.shtml).
- World Health Organization (WHO) (1986). A Multicentered Phase III Comparative Clinical Trial of Depot-medroxyprogesterone Acetate Given in Three-monthly at Doses of 100mg or 150mg: I. Contraceptive Efficacy and Side Effects , Contraception 34 (3): 223–35 .[CrossRef][Medline]
[Order article via Infotrieve]
- World Health Organization (WHO) (2004) Scaling up Antiretroviral Therapy in Resource-limited Settings: Treatment Guidelines for a Public Health Approach. Geneva , WHO, 68 pp. (Available at http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf)
Gender, Technology and Development, Vol. 11, No. 3,
417-427 (2007)
DOI: 10.1177/097185240701100308

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|